Ach Taieb, Yosra Hasni, Jihen Maatoug, Abdelkarim Asma Ben, Maha Kacem, Molka Chaieb, Rouatbi Sonia, Monia Zaouali, Ach Koussay
Department of Endocrinology and Diabetology, University Hospital of Farhat Hached, Sousse, Tunisia.
Department of Epidemiology, University Hospital of Farhat Hached, Sousse, Tunisia.
Endocr J. 2018 Sep 27;65(9):935-942. doi: 10.1507/endocrj.EJ18-0147. Epub 2018 Jun 27.
Diagnosis of adrenal insufficiency requires evaluation by dynamic stimulation tests. The insulin tolerance test (ITT) is accepted as the gold-standard test for the evaluation of hypothalamo-pituitary-adrenal (HPA) axis but the test is unpleasant and dangerous. Although it takes more time, glucagon stimulation test (GST) is a good alternative to ITT. The primary aim of this study was to compare the ITT and GSTs in the evaluation of HPA axe in patients with pituitary disorders. We conducted a prospective study in which ITT and GST were performed within 7 days in 81 patients. Serum cortisol was measured. We divided our population in Group 1 (G1): Adrenal Insufficiency (Peak cortisol under ITT <200 ng/mL) and Group 2 (G2): normal response (Peak cortisol under ITT >200 ng/mL). Receiver-operating characteristic (ROC) analysis was performed to identify the thresholds for GST. The mean peak of cortisol under GST was not significantly different from that obtained after ITT in the whole cohort (182.67 ± 89.07 ng/mL vs. 179.75 ± 79.01 ng/mL), and it was significantly reduced in patients of G1 (p < 10). ROC curve analysis showed that the best diagnostic accuracy was obtained with a peak cortisol cut-off to GST of 167 ng/mL (sensitivity, 89%; specificity, 79%). Using this cut-off, 86.4% of the patients were correctly classified. In our prospective series, GST is a potential accurate and safe alternative test for the assessment HPA. Test-specific cut-offs should be applied to avoid misinterpretation.
肾上腺功能不全的诊断需要通过动态刺激试验进行评估。胰岛素耐量试验(ITT)被公认为评估下丘脑 - 垂体 - 肾上腺(HPA)轴的金标准试验,但该试验令人不适且有风险。虽然需要更多时间,但胰高血糖素刺激试验(GST)是ITT的良好替代方法。本研究的主要目的是比较ITT和GST在评估垂体疾病患者HPA轴方面的效果。我们进行了一项前瞻性研究,对81例患者在7天内进行了ITT和GST,并测量了血清皮质醇。我们将研究人群分为1组(G1):肾上腺功能不全(ITT时皮质醇峰值<200 ng/mL)和2组(G2):正常反应(ITT时皮质醇峰值>200 ng/mL)。进行了受试者操作特征(ROC)分析以确定GST的阈值。在整个队列中,GST时皮质醇的平均峰值与ITT后获得的峰值无显著差异(182.67±89.07 ng/mL对179.75±79.01 ng/mL),而在G1组患者中显著降低(p<0.01)。ROC曲线分析表明,当GST的皮质醇峰值截断值为167 ng/mL时,诊断准确性最佳(敏感性89%;特异性79%)。使用该截断值,86.4%的患者被正确分类。在我们的前瞻性系列研究中,GST是评估HPA的一种潜在准确且安全的替代试验。应应用特定试验的截断值以避免误解。